Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Screening Tools to Better Predict High-Grade Anal Dysplasia for MSM

NCT02816879 is registered in ClinicalTrials.gov with Jonsson Comprehensive Cancer Center as lead sponsor.

NCT NCT02816879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02816879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Screening Tools to Better Predict High-Grade Anal Dysplasia for MSM
Lead sponsor
Jonsson Comprehensive Cancer Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 1, 2013
Completion date
June 1, 2028
Enrollment
415 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

anal carcinoma, hiv infection, human papillomavirus infection